文献速递运动医学关节外科

骨-髌腱-骨与腘绳肌腱自体移植物行初次前交叉韧带重建后重返运动和移植失败率的系统评价与荟萃分析

Return to Sport and Graft Failure Rates After Primary Anterior Cruciate Ligament Reconstruction With a Bone-Patellar Tendon-Bone Versus Hamstring Tendon Autograft: A Systematic Review and Meta-analysis.
PubMed 文献 · Am J Sports Med · 2025-01-21

该系统评价与荟萃分析纳入33项研究、4810例运动员,比较骨-髌腱-骨(BTB)与腘绳肌腱(HT)自体移植物行初次前交叉韧带重建后的重返运动率、恢复伤前活动水平和移植再断裂率。总体重返运动率为80.4%,恢复伤前活动水平为54.6%,总体移植再断裂率为3.6%;BTB与HT在重返运动、恢复伤前活动水平和再断裂率方面均无显著差异。

要点

  • 初次前交叉韧带重建后总体重返运动率为80.4%(95%CI,75.3%-84.6%),平均随访35.7个月。
  • BTB组重返运动率83.3%(95%CI,77.0%-88.2%)与HT组77.9%(95%CI,70.3%-84.0%)无显著差异。
  • BTB组移植再断裂率3.2%(95%CI,1.9%-5.3%)与HT组4.4%(95%CI,2.8%-6.8%)无显著差异。

核心结论

  • 使用BTB自体移植物行初次前交叉韧带重建在重返运动率、恢复伤前活动水平和移植再断裂率方面与使用HT自体移植物相似。

研究设计与样本

  • 系统评价与荟萃分析,证据等级为4级;检索MEDLINE、Embase和Cochrane Library数据库。
  • 纳入报告BTB或HT自体移植物行初次前交叉韧带重建后重返运动的研究,排除翻修重建、前交叉韧带修复、股四头肌腱自体移植物、同种异体移植物、移植物增强或双束自体移植物。
  • 共纳入33篇文章,患者队列为4810例运动员。

主要发现

  • 所有运动员总体重返运动率为80.4%(95%CI,75.3%-84.6%),平均随访35.7个月,恢复伤前活动水平率为54.6%(95%CI,48.5%-60.6%)。
  • BTB自体移植物行初次前交叉韧带重建后总体重返运动率为83.3%(95%CI,77.0%-88.2%),恢复伤前活动水平率为56.1%(95%CI,49.3%-62.7%)。
  • HT自体移植物行初次前交叉韧带重建后总体重返运动率为77.9%(95%CI,70.3%-84.0%),恢复伤前活动水平率为53.5%(95%CI,42.8%-63.9%)。
  • 整个患者队列总体移植再断裂率为3.6%(95%CI,2.5%-5.1%),BTB组为3.2%(95%CI,1.9%-5.3%),HT组为4.4%(95%CI,2.8%-6.8%)。
  • BTB与HT自体移植物在重返运动率、恢复伤前活动水平率或再断裂率方面均无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Anterior cruciate ligament (ACL) tears are frequent injuries in athletes that often require surgical reconstruction so that patients may return to their previous levels of performance. While existing data on patient-reported outcomes are similar between bone-patellar tendon-bone (BTB) and hamstring tendon (HT) autografts, the literature regarding return to sport (RTS), return to previous levels of sport activity, and graft failure rate remains limited. PURPOSE: To compare rates of RTS, return to previous activity levels, and graft retears among athletes undergoing primary ACL reconstruction using a BTB versus HT autograft. STUDY DESIGN: Systematic review and meta-analysis; Level of evidence, 4. METHODS: The MEDLINE, Embase, and Cochrane Library databases were queried, and studies reporting on RTS after primary ACL reconstruction using a BTB or HT autograft were included. Exclusion criteria included revision reconstruction, ACL repair, quadriceps tendon autografts, allografts, graft augmentation, or double-bundle autografts. Rates of RTS, return to previous levels of activity, and retears were extracted and analyzed across included studies. RESULTS: A total of 33 articles met inclusion criteria, with a patient cohort of 4810 athletes. The overall RTS rate for all athletes was 80.4% (95% CI, 75.3%-84.6%) at a mean follow-up of 35.7 months, with 54.6% (95% CI, 48.5%-60.6%) returning to preinjury levels of activity. No significant difference was found between BTB and HT autografts with respect to rates of RTS, return to preinjury activity levels, or reruptures. The overall RTS rate in patients after primary ACL reconstruction with a BTB autograft was 83.3% (95% CI, 77.0%-88.2%), with 56.1% (95% CI, 49.3%-62.7%) returning to preinjury levels of activity. Conversely, the overall RTS rate in patients after primary ACL reconstruction with an HT autograft was 77.9% (95% CI, 70.3%-84.0%), with 53.5% (95% CI, 42.8%-63.9%) returning to preinjury levels of activity. The overall graft rerupture rate for the entire patient cohort was 3.6% (95% CI, 2.5%-5.1%), for patients with BTB grafts was 3.2% (95% CI, 1.9%-5.3%), and for patients with HT grafts was 4.4% (95% CI, 2.8%-6.8%). CONCLUSION: Primary ACL reconstruction using BTB autografts demonstrated similar rates of RTS, return to previous activity levels, and reruptures compared with reconstruction using HT autografts.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Connors JP, Cusano A, Saleet J, et al. Return to Sport and Graft Failure Rates After Primary Anterior Cruciate Ligament Reconstruction With a Bone-Patellar Tendon-Bone Versus Hamstring Tendon Autograft: A Systematic Review and Meta-analysis. Am J Sports Med. 2025. PMID: 39836368. doi:10.1177/03635465241295713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。